CDKN2A and metabolic dysfunction-associated steatohepatitis: The group also introduced a Diphtheria Toxin Receptor (DTR) element to specifically ablate p16-high cells, which resulted in reduced steatosis and liver inflammation in a nonalcoholic steatohepatitis (NASH) model.